Tomonori Tawara

Title: Tomonori Tawara: Innovator in Antibody Development

Introduction

Tomonori Tawara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 6 patents to his name, Tawara's work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

One of Tawara's latest patents involves an anti-TIM-3 antibody. This invention discloses an anti-human TIM-3 antibody that exhibits high antibody-dependent cellular cytotoxicity (ADCC) activity. The patent details the process of screening a monoclonal antibody or its fragment that binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure. It also includes a hybridoma that produces the antibody, a DNA encoding the antibody, and a vector comprising the DNA. Furthermore, it describes a transformant obtainable by introducing the vector, a method for producing the antibody or its fragment using the hybridoma or transformant, and a therapeutic agent and diagnostic agent that utilize the antibody or its fragment as an active ingredient.

Career Highlights

Throughout his career, Tomonori Tawara has worked with notable organizations such as Kyowa Hakko Kirin Co., Limited and Kyushu University. His experience in these institutions has allowed him to advance his research and contribute to the field of antibody development.

Collaborations

Tawara has collaborated with esteemed colleagues, including Yoshimasa Inagaki and Shin-ichiro Takayanagi. These partnerships have fostered innovation and have been instrumental in his research endeavors.

Conclusion

Tomonori Tawara is a distinguished inventor whose work in antibody development is paving the way for advancements in medical therapies and diagnostics. His contributions are significant and continue to influence the field of biotechnology.